Overexpression of P-gp in cancers results in reduced accumulation of chemotherapeutics and leads to resistance against many of the currently available anti-cancer drugs such as taxanes (paclitaxel), vinca alkaloids (vinblastine), and anthracyclines (daunorubicin)13. The gene discussed is PGP; the disease is cancer.